The PGAM2 gene helps skeletal muscles turn stored sugar into usable energy, especially during exercise. When it does not work properly, muscles may run short on energy, leading to early fatigue, cramps, pain, or episodes of muscle breakdown after hard activity. A harmful variant in both copies of this gene can cause a rare inherited muscle condition called glycogen storage disease type X.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes hold the instructions for producing proteins, which are the working parts of cells. Others mainly direct when certain processes happen, where they take place, and how strongly they run. Together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. To look into this topic in more detail, you can find more in the LearnHub.
Overview
PGAM2Gene function
What if the gene works
The PGAM2 gene helps muscle cells turn stored sugar into usable energy. It makes an enzyme used during glycolysis, a stepwise process cells use to release energy, especially during exercise.
Risk
What if the gene does not work
When the PGAM2 gene does not work well, muscle cells struggle to make energy during exercise. People may develop exercise intolerance, cramps, or muscle breakdown with dark urine, with milder to more severe effects depending on the variant.
Treatment
What does that mean for your treatment
For pathogenic variants in the PGAM2 gene, no PGAM2-specific treatment or management approach is currently established in clinical guidelines. The PGAM2 gene is being studied mainly as a metabolic marker and possible drug target in some cancers rather than as a guide to approved treatment.
Conditions associated with PGAM2
Gene function
What if the gene works
Your muscles need a fast, steady way to turn sugar into usable energy, especially during movement. The PGAM2 gene helps with one of the middle steps in that process, mainly in skeletal muscle. When it is working as expected, muscle cells can keep this energy pathway moving smoothly during everyday activity and exercise.
One role of the PGAM2 gene is to keep glycolysis (the step by step process that turns sugar into energy) moving in muscle cells. It helps convert one small sugar byproduct into the next form needed for continued energy production.
This step is part of how the PGAM2 gene helps muscles make energy during activity and exercise. Skeletal muscle relies on this fast pathway when demand rises with walking, climbing stairs, or sports.
The PGAM2 gene is most active in skeletal muscle, where cells often need quick energy from sugar. Its protein supports routine muscle work as well as short bursts of stronger effort.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These differences are common and help shape normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the PGAM2 gene can alter the enzyme’s shape or stability, so muscle cells make less working protein or a protein with much lower activity. Some missense variants leave partial activity, while more disruptive variants can greatly reduce or eliminate function. This range helps explain how PGAM2 gene variants and muscle energy production are linked, with stronger loss of function often tied to earlier or more marked exercise-related symptoms.
How variants are linked to conditions
Pathogenic variants in the PGAM2 gene cause glycogen storage disease type X, a rare inherited muscle condition. People with this diagnosis often have exercise intolerance, muscle cramps, and episodes of dark urine after strenuous activity, which can reflect muscle breakdown. In clinical genetics, PGAM2 gene variants and glycogen storage disease type X are a well-established pairing, and finding a pathogenic variant can help confirm the diagnosis.
A variant is not necessarily a diagnosis
Variants in genes are a routine feature of human biology and are widely seen across the general population. Most do not have a direct effect on health and simply contribute to normal human variation. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, one well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For PGAM2, the main risk comes from inheritance: people usually develop this condition only if they are born with changed copies of the PGAM2 gene from both parents. In people living with PGAM2-related muscle disease, hard or sudden intense exercise can make symptoms and muscle breakdown episodes more likely.
Inheritance of PGAM2 variants
Variants in the PGAM2 gene linked to PGAM2 related muscle glycogen storage disease are inherited in an autosomal recessive pattern. This means a person usually inherits one altered copy from each parent. Parents who each carry one PGAM2 variant are often unaffected, and with each pregnancy there is a 25% chance for an affected child, a 50% chance for a child who is a carrier, and a 25% chance for a child with two nonworking copies. In practical terms, the PGAM2 inheritance pattern means it can appear in brothers or sisters even when neither parent has symptoms.
What does my PGAM2 result mean for my family?
For families with a PGAM2-related condition, close relatives may also carry the gene change even if they have no symptoms. Brothers and sisters can sometimes be affected or be carriers, and other blood relatives may also carry the same change. This kind of result often matters most for family planning, because two carriers can have a child with the condition.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant, PGAM2 genetic testing analyzes DNA from blood, saliva, or a cheek swab. The lab reads the PGAM2 gene and reports a pathogenic variant, a benign variant, or a variant of uncertain significance.
When should I consider getting a genetic test?
Consider genetic testing for the PGAM2 gene if there is a personal or family history of severe exercise intolerance, painful muscle cramps, or episodes of dark urine after activity, which can signal muscle breakdown. Testing can help confirm an inherited muscle energy condition and clarify risks for relatives.
A genetic result is only one part of your health story
Genetic test results can provide useful insight, but how much they explain varies based on the condition and the kind of variant involved. Many factors, including lifestyle, environment, age, and medical history, also shape how the body works over time. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result can offer a clear answer. In areas like medication response, these results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same drug may work well for one person, have less effect in another, or cause more side effects in someone else. One reason is that inherited differences can change how the body absorbs, breaks down, or responds to a medication, and these differences are common.
What is Pharmacogenetics?
Pharmacogenetics examines the ways genetic differences can affect a person’s response to medicines. By looking at connections between genes and medications, it helps explain why the same treatment may work differently from one person to another. For many drugs, genes influence both how strongly a medicine works and how the body handles it. This information can support more informed, individualized treatment decisions. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the PGAM2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work or whether side effects are more likely. If you have questions about symptoms, treatment, or medicine side effects, it is best to discuss them with your doctor.
History
PGAM2 entered the medical literature through reports of people with exercise related muscle symptoms that were later linked to phosphoglycerate mutase deficiency, a rare glycogen storage condition. Initially understood only through visible traits, later recognized as tied to a specific gene, this work helped connect a distinctive pattern of cramps, pain, and episodes of dark urine with an inherited cause. From these first observations, research expanded steadily. Scientists then mapped and sequenced the PGAM2 gene, confirming that harmful variants in this gene explain the muscle form of the condition. Over time, descriptions became more precise, and PGAM2 found its place in the broader history of rare inherited muscle conditions.